FDA Investigator Corey K Reno

Corey K Reno has conducted inspections on 113 sites in 9 countries as of 02 May 2024. See below for a list of the FDA enforcement documents resulting from those inspections.

Investigator Details

Number of Inspected Sites:
113
Last Inspection Date:
02 May 2024
Investigator Role:
FDA Investigator
Redica ID:
100002483
Countries of Inspections:
United States of America, Germany, Turkey, Costa Rica, Czechia, United Kingdom of Great Britain and Northern Ireland, France, Poland, Sweden
FDA Investigators that have inspected at least one site in common with Corey K Reno:
Aaron L Dunbar, Albert L Nguyen, Althea A Williams, Amanda Dinaro, Amir Alavi, Andrea A Branche, April L Young, Barbara A Rusin, Benjamin W Anderson, Billi Jom Johnson, Brian L Szcyubialka, Brittani N Franklin, Byron Ho, DVM, Carol Rivera Lopez, PhD, Caryn M Mcnab, Chad E Schmear, Charles A Snipes, PhD, Charles R Bonapace, PhD, Charles R Cote, RIC, Chase Bourke, PhD, Chelsea W Lamm, Chris A Sack, Christina A Castineyra, Coreyk Zelinski, David M Beltran, Dawn C Olenjack, Demetria L Lueneburg, Denise L Burosh, Diane Kretschmer, Diane T Reindl, Dina A Tallman, Douglas W Gronski, Dr. Gopa Biswas, PhD, Dr. Hansong Chen, PhD, Dr. Mark J Seaton, PhD, Dr. Zhou Chen (nmi), MD PhD, Dylan D Yao, MD, PhD, Edward E Lockwood (EEL), Edwin Melendez, Elizabeth D Connell, Elizabeth P Mayer, Emma R Schaefer, Eric C Fox, Eric S Myskowski, Eric S Pittman, Francis A Guidry, Frank S Sedzielarz, Gajendiran Mahadevan, PhD, George R Smith, George T Allen, Jr, Gloria A Milster, Gregory W Smith, Howard A Burmester, Hyojong Kwon, PhD, Jaclyn N Munsch, James A Beaulieu, James K Ireland, Jane E Nelson, Janis R Armedoriz, Jasjeet K Sekhon, Jeffry A Bernhardt, Jennifer C Adams, Jennifer C Johnson, Jennifer M Gogley, Jennifer S Ness, Jesse P Romenesko, Jessica L Johnson, Joel D Hustedt, John A Kadavil, PhD, John E Emmert, John P Hermann, Jon C Polzine, Joseph M Edwin, Joseph R Haynes, Justin A Boyd, Justin J Jafferis, Justine Tomasso, Jyoti B Patel, PhD, Kara A Scheibner, PhD, Katherine A Clarke Girolamo, Kellie L Thommes, RN, Kenneth A Libertoski, Kim M Wiegand, Kimberly Lewandowski Walker, Kimberly W Destromp, Laureen M Geniusz, Linda A Gregory Duty, Lisa M Lopez, Marie A Fadden, Marissa S Steinhagen, Martin K Yau, PhD, Mary K Concannon, Maryam Tabatabaie, Maya M Davis, Melanie C Voges, Melissa I Michurski, Melissa J Holz, Michael F Skelly, PhD, Michael R Goga, Michelle J Glembin, Michelle J Hines, Mohsen Rajabi Abhari, FDA, Monica J Wilkins, Mra Davism, Mra M Barbosar, Nancy A Bellamy, Natalie A Mickelsen, DVM, Natasha R Johnson, Nicholas T Domer, Nicole C Victoria, PhD, Niraj R Mehta, PhD, Paul R Whitby, Peter T Erlandson, Rafael A Kaup, Ralph A Erickson, Ralph Jerndal, Rebecca L Mullikin, Reginald Walker, Richard Jay Tucker, RS, Rochelle K Kimmel, Ronald R Ruff, Sandra A Hughes, Sandra Sejdinovic, Sarah A Palmer, Scott A Golladay, Scott B Laufenberg, Scott L Schenian, Shalonda C Clifford, Sharon K Thoma, PharmD, Sharon L Matson, Sripal R Mada, PhD, Stephen T Hansen, Steven P Donald, Susan M Jackson, Susan M Matthias, Susan M Miller, Tania E Vizcaino, Tara C Singh, Tara M Aikens, Tara M Carolfi, Tara M Humfeld, Thomas J Arista, Thomas W Garvin, Tiara Nbrown Crosen, Tracey Asinjen Wiersma, Traci C Kelm, Tyler R Courtney, Tyson J Eldridge Stedman, Victor Spanioli, Wendy M Stone, William D Tingley, William E Keer, William P Fournier, Xiaohan Cai, PhD, Xikui Chen (nmi), PhD, Yehualashet A Gessesse

Corey K Reno's Documents

Publish Date Document Type Title
June, 2012 FDA 483 Kimberly-clark Corporation - Form 483, 2012-06-08
December, 2013 FDA 483 Maquet Cardiopulmonary Medical Teknik San. Tic. Ltd. Sti. - Form 483, 2013-11-14
February, 2016 FDA 483 Response Mercy Health System IRB - Form 483R, 2016-02-10
June, 2018 EIR Charles River Laboratories - EIR, 2018-06-28
December, 2014 EIR Epic Systems Corporation - EIR, 2014-12-12
December, 2014 FDA 483 Epic Systems Corporation - Form 483, 2014-12-12
February, 2016 FDA 483 Mercy Health System IRB - Form 483, 2016-02-01
February, 2012 EIR Trek Diagnostics Systems Inc. (dba Thermo Fisher Scientific) - EIR, 2012-02-07
April, 2016 EIR Brian E. Driver, MD, Sponsor/Investigator - EIR, 2016-04-22
October, 2015 FDA 483 Nancy Sweitzer - Form 483, 2015-10-30
April, 2016 FDA 483 Response Brian E. Driver, MD, Sponsor/Investigator - Form 483R, 2016-05-06
April, 2012 FDA 483 Orbital Technologies Corporation (Orbitec) - Form 483, 2012-04-06
September, 2012 EIR Zoll Medical Corporation - EIR, 2012-09-18
July, 2017 FDA 483 Nathan Smischney - Form 483, 2017-07-05
June, 2011 FDA 483 Quantum Devices, Inc. - Form 483, 2011-06-10
January, 2011 FDA 483 Datex-Ohmeda, Inc. - Form 483, 2011-01-28
February, 2014 EIR Labcorp Early Development Laboratories, Inc. - EIR, 2014-02-20
February, 2014 FDA 483 Labcorp Early Development Laboratories, Inc. - Form 483, 2014-02-20
February, 2014 EIR PPD Development, L.P. - EIR, 2014-02-13
April, 2016 FDA 483 Brian E. Driver, MD, Sponsor/Investigator - Form 483, 2016-04-22
March, 2018 EIR Dean Institutional Review Board - EIR, 2018-03-19
April, 2014 FDA 483 SAFC Inc - Form 483, 2014-04-25
April, 2016 EIR Labcorp Early Development Laboratories, Inc. - EIR, 2016-04-08
February, 2015 FDA 483 Wilson Hurd - Form 483, 2015-02-18
January, 2014 FDA 483 Maquet Cardiopulmonary Ag - Form 483, 2013-11-21
December, 2018 FDA 483 Sanjeev Puri, Clinical Investigator - Form 483, 2018-12-14
November, 2014 EIR Labcorp Early Development Laboratories, Inc. - EIR, 2014-11-03
September, 2014 FDA 483 Wakai, Ronald, Ph. D., Clinical Investigator - Form 483, 2014-08-22
March, 2018 FDA 483 Response Dean Institutional Review Board - Form 483R, 2018-03-29
July, 2018 FDA 483 Avera McKennan Hospital IRB #1 DBA Avera IRB #1 - Form 483, 2018-08-08
April, 2018 EIR Covance Cru Inc - EIR, 2018-04-06
November, 2014 FDA 483 Labcorp Early Development Laboratories, Inc. - Form 483, 2014-11-03
October, 2015 EIR Nancy Sweitzer - EIR, 2015-09-30
September, 2014 EIR Wakai, Ronald, Ph. D., Clinical Investigator - EIR, 2014-08-22
October, 2015 FDA 483 Response Nancy Sweitzer - Form 483R, 2015-10-16
March, 2018 FDA 483 Dean Institutional Review Board - Form 483, 2018-03-19
March, 2013 FDA 483 Biocomposites, Ltd. - Form 483, 2013-02-07
February, 2012 FDA 483 Trek Diagnostics Systems Inc. (dba Thermo Fisher Scientific) - Form 483, 2012-02-07
November, 2018 FDA 483 Mercedes Samson - Form 483, 2018-11-02
March, 2011 FDA 483 H & P Industries, Inc. - Form 483, 2011-03-28
November, 2017 FDA 483 St Mary's Hospital IRB - Form 483, 2017-11-21
August, 2018 FDA 483 Labcorp Early Development Laboratories, Inc. - Form 483, 2018-08-17
August, 2017 FDA 483 Mercy Health System IRB - Form 483, 2017-08-03
July, 2013 FDA 483 GE Medical Systems, LLC - Form 483, 2013-07-31
May, 2011 EIR Nuk Usa Llc - EIR, 2011-05-03
June, 2014 EIR PPD Development, L.P. - EIR, 2014-06-20
April, 2017 FDA 483 Mayo Clinic IRB - Form 483, 2017-04-28
September, 2012 FDA 483 Zoll Medical Corporation - Form 483, 2012-09-18
April, 2016 FDA 483 Labcorp Early Development Laboratories, Inc. - Form 483, 2016-04-08
February, 2012 FDA 483 Magellan Biosciences, Inc. - Form 483, 2012-02-23
October, 2011 FDA 483 INO Therapeutics (dba Ikaria) - Form 483, 2011-10-21

Experience Redica Systems’ NEW investigator profiles and dashboards

Redica Systems customers get access to over 1,400 FDA Investigator profiles, containing powerful analysis like:

  • Total inspections conducted
  • 483 rate
  • OAI rate
  • Warning Letter rate
  • Inspections by Industry, Scope, and Inspection Reason
  • And much more

Investigator Profiles are not sold as on-demand documents. If you’d like to see one, fill out the form below to connect with our Sales Team and get it in your inbox as little as 24 hours.

FDA Investigator Profile Icon

Talk to sales to access our investigator profiles

Loading...

Investigator Profiles Are Just the Tip of the Iceberg

Becoming a Redica Systems customer not only provides you with unlimited access to profiles similar to the one above for every current and former FDA Investigator, but also grants you access to:

Inspection Intelligence

  • Pre-Approval Inspection (PAI) trends
  • The ability to filter nearly any FDA enforcement action by GxP labels like GMP, GCP, etc.
  • Latest 483s: see what the trends are across all FDA Investigators
  • CFR Heatmap: Citations aggregated by Subpart by Year

Vendor Intelligence

  • Full inspection histories for your vendors down to the specific site level
  • All of the functionality mentioned above but isolated to just your vendors

Regulatory Intelligence

  • Zero in on the trends for a specific agency/regulator (ex. FDA, MHRA, EMA, Health Canada)
  • All the latest "Signals" from agencies around the world, segmented by Country, Type (ex. Guidance, Decree...), Category (ex. Rules/Regulations/Guidance, News, Reports...), Theme (ex. Cell and Gene Therapy, AI...), and more